DEA Emergency Scheduling of 7-OH Sets August 5 as Drop-Dead Date for Kratom Extracts

Why it matters

The DEA's move to temporarily schedule 7-OH uses emergency authority that bypasses the normal notice-and-comment process, accelerating federal restriction of concentrated kratom products with fewer procedural safeguards than traditional rulemaking. The order cannot take effect before August 5, 2026, giving retailers and users a narrow window.

The big picture

Unlike the 2016 kratom scheduling attempt that collapsed under public and legislative pressure, this action targets only concentrated and semi-synthetic 7-OH, drawing an explicit line between botanical kratom leaf and manufactured extracts. Congress is tracking closely: H.R. 8000, the END 7-OH Act, would codify that same distinction in permanent law. The federal government is using emergency drug authority to keep pace with a synthetic kratom market that barely existed five years ago.

Key findings

• DEA announced its intent on July 1, 2026; the Federal Register notice confirms the temporary order cannot take effect before August 5, 2026
• The order targets 7-OH above a 0.05% threshold, plus three fully synthetic derivatives: mitragynine pseudoindoxyl, MGM-15, and MGM-16
• H.R. 8000, the END 7-OH Act, was introduced March 19, 2026 and would permanently schedule synthetic 7-OH while explicitly protecting natural kratom leaf
• NIDA reports 7-OH can cause opioid-like respiratory depression reversible by naloxone, a property not documented for mitragynine or kratom leaf
• HHS told DEA that covered substances have no accepted medical use and a high potential for abuse

What they say

"Today's action targets highly concentrated, synthetic 7-OH products, which pose a growing threat to public safety and health," said DEA Administrator Terrance Cole in the agency's July 1 announcement.

Bottom line

The DEA's 7-OH scheduling order drops no earlier than August 5, 2026, using emergency authority that skips judicial review — the fastest and least reversible federal drug action in kratom's regulatory history.